Bio Green Med Solution, Inc. BGMS
Wholesale-Durable Goods, NEC · CIK 0001130166 · Fiscal year ends 1231
Revenue
$0
Fiscal year ended 2025-12-31Operating income
-$8.43M
Fiscal year ended 2025-12-31Free cash flow
—Unavailable
Fiscal year ended 2025-12-31Valuation, from the filing
| Public float | $3.02M | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|
| Float per share | $0.55 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
|---|
| Float / equity | 0.4× | A lower bound on the multiple, because affiliate holdings are excluded. |
|---|
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
Bio Green Med Solution, Inc. (BGMS) reported revenue of $0 and net income of -$3.00M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Bio Green Med Solution, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Wholesale-Durable Goods, NEC.
Income
Bio Green Med Solution, Inc. income by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|
| Revenue | $0 | $43.00K | $420.00K | $0 | $0 | $0 | $150.00K | $0 | $843.00K | $1.94M |
|---|
| Cost of revenue | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Gross profit | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Operating income | -$8.43M | -$12.00M | -$25.45M | -$27.66M | -$22.39M | -$10.64M | -$9.55M | -$9.49M | -$14.15M | -$16.17M |
|---|
| Net income | -$3.00M | -$11.21M | -$22.56M | -$21.20M | -$18.46M | -$8.44M | -$7.29M | -$7.47M | -$11.79M | -$14.34M |
|---|
| Research & development | $848.00K | $6.66M | $19.16M | $20.27M | $14.93M | $4.76M | $4.33M | $4.24M | $9.48M | $12.38M |
|---|
| Weighted-average diluted shares | shares 2.19M | —Unavailable | shares 3.54M | shares 11.26M | shares 8.93M | shares 3.63M | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Pretax income | -$2.99M | -$11.99M | -$25.55M | -$25.92M | -$22.18M | -$9.68M | -$8.62M | -$8.46M | -$13.77M | -$16.49M |
|---|
| Income tax expense | $7.00K | -$782.00K | -$3.00M | -$4.72M | -$3.73M | -$1.24M | -$1.34M | -$993.00K | -$1.98M | -$2.14M |
|---|
| Diluted EPS | $-6.45 | $-502.46 | $-6,419.18 | $-27.24 | $-2.09 | $-3.42 | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Selling, general & administrative | —Unavailable | $5.39M | $6.72M | $7.38M | $7.46M | $5.88M | $5.37M | $5.25M | $5.52M | $5.73M |
|---|
| General & administrative | $7.72M | $5.39M | $6.72M | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Selling & marketing | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Balance
Bio Green Med Solution, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|
| Cash & equivalents | $3.50M | $3.14M | $3.38M | $18.34M | $36.56M | $33.41M | $17.50M | $23.91M | $16.52M | $20.44M |
|---|
| Total assets | $8.18M | $4.09M | $8.80M | $28.05M | $43.14M | $36.80M | $19.82M | $26.00M | $19.66M | $24.76M |
|---|
| Current assets | $6.26M | $3.67M | $7.44M | $24.41M | $40.94M | $35.47M | $19.79M | $25.97M | $19.62M | $24.57M |
|---|
| Total liabilities | $1.34M | $6.27M | $8.20M | $7.62M | $5.44M | $3.54M | $4.55M | $4.24M | $5.39M | $5.93M |
|---|
| Current liabilities | $1.33M | $6.27M | $8.16M | $7.51M | $5.41M | $2.49M | $4.45M | $4.11M | $5.26M | $5.75M |
|---|
| Total equity incl. NCI | $6.84M | -$2.17M | $607.00K | $15.94M | $37.69M | $33.26M | $15.27M | $21.77M | $14.27M | $18.84M |
|---|
| Temporary (mezzanine) equity | —Unavailable | —Unavailable | $0 | $4.49M | $0 | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Inventory | $1.38M | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Accounts receivable | $1.26M | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | $10.00K | —Unavailable |
|---|
| Goodwill | $1.57M | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Long-term debt | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Accounts payable | $617.00K | $4.60M | $3.54M | $2.56M | $2.12M | $514.00K | $2.72M | $1.56M | $2.50M | $1.94M |
|---|
Cash flow
Bio Green Med Solution, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|
| Operating cash flow | -$4.77M | -$7.99M | -$16.11M | -$20.83M | -$18.54M | -$7.93M | -$6.70M | -$7.48M | —Unavailable | —Unavailable |
|---|
| Capital expenditures | —Unavailable | —Unavailable | $6.00K | $7.00K | $27.00K | $96.00K | $39.00K | $13.00K | $3.00K | $34.00K |
|---|
| Investing cash flow | —Unavailable | —Unavailable | -$6.00K | -$7.00K | -$27.00K | -$96.00K | -$39.00K | -$13.00K | —Unavailable | —Unavailable |
|---|
| Financing cash flow | $5.26M | $7.82M | $848.00K | $3.00M | $21.74M | $29.50M | $429.00K | $14.75M | —Unavailable | —Unavailable |
|---|
| Net change in cash | $368.00K | -$241.00K | -$14.97M | -$18.21M | $3.15M | $21.52M | -$6.41M | $7.39M | -$3.92M | -$3.75M |
|---|
| Stock-based compensation | $2.33M | $592.00K | $1.47M | $1.51M | $1.16M | $430.00K | $331.00K | $266.00K | $782.00K | $745.00K |
|---|
| Common dividends paid | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Common share repurchases | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Depreciation & amortization | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | $20.00K | $29.00K | $32.00M | $100.00K | $200.00K |
|---|
Derived
Bio Green Med Solution, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|
| Free cash flow | —Unavailable | —Unavailable | -$16.12M | -$20.83M | -$18.57M | -$8.03M | -$6.74M | -$7.49M | —Unavailable | —Unavailable |
|---|
| Gross margin | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Operating margin | —Unavailable | -27916.3% | -6060.2% | —Unavailable | —Unavailable | —Unavailable | -6365.3% | —Unavailable | -1678.5% | -831.8% |
|---|
| FCF margin | —Unavailable | —Unavailable | -3837.6% | —Unavailable | —Unavailable | —Unavailable | -4493.3% | —Unavailable | —Unavailable | —Unavailable |
|---|
| SBC / revenue | —Unavailable | 1376.7% | 350.7% | —Unavailable | —Unavailable | —Unavailable | 220.7% | —Unavailable | 92.8% | 38.3% |
|---|
| Current ratio | 4.70x | 0.59x | 0.91x | 3.25x | 7.56x | 14.27x | 4.45x | 6.32x | 3.73x | 4.27x |
|---|
| Revenue YoY growth | -100.0% | -89.8% | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | -100.0% | -56.6% | —Unavailable |
|---|
| Net margin | —Unavailable | -26074.4% | -5370.2% | —Unavailable | —Unavailable | —Unavailable | -4858.7% | —Unavailable | -1398.7% | -737.8% |
|---|
| R&D / revenue | —Unavailable | 15476.7% | 4560.7% | —Unavailable | —Unavailable | —Unavailable | 2884.7% | —Unavailable | 1124.2% | 636.9% |
|---|
| CapEx / revenue | —Unavailable | —Unavailable | 1.4% | —Unavailable | —Unavailable | —Unavailable | 26.0% | —Unavailable | 0.4% | 1.7% |
|---|
| Long-term debt / equity | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Effective tax rate | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BGMS in the interactive workspace to inspect any figure back to its filing.
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.